PHASE I TRIAL OF AdR SVtk VIRUS WITH GANCICLOVIR IN 
PATIENTS WITH UNRESECTABLE MALIGNANT 
MESOTHELIOMA 
UPCC 2594 
SIGNIFICANT NEW FINDINGS 
Any significant new findings resulting from this study will be made known to me and my family. 
To Find out more about any aspect of this study, I may contact the persons whose names, addresses and 
telephone numbers appear below: If significant new knowledge is obtained during the course of this 
research which may relate to my willingness to continue participation, I will be informed of this 
knowledge. 
Joseph Treat, M.D. 
Associate Professor of Medicine 
Hospital of the University of Pennsylvania 
3400 Spruce Street 
6 Penn Tower 
Philadelphia, PA 19104 
215-662-7711 
Steven M. Albelda, M.D. 
Associate Professor of Medicine 
Hospital of the University of Pennsylvania 
3400 Spruce Street 
809 Maloney Building 
Philadelphia, PA 19104 
215-662-3307 
[420] 
Recombinant DNA Research, Volume 20 
